Literature DB >> 16825321

Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation.

Soraya Taleb1, Raffaella Cancello, Karine Clément, Daniele Lacasa.   

Abstract

We previously showed that the cysteine protease cathepsin S (CTSS), known to degrade several components of the extracellular matrix (ECM), is produced by human adipose cells and increased in obesity. Because ECM remodeling is a key process associated with adipogenesis, this prompted us to assess the potential role of CTSS to promote preadipocyte differentiation. Kinetic studies in primary human preadipocytes revealed a modest increase in CTSS gene expression and secretion at the end of differentiation. CTSS activity was maximal in preadipocyte culture medium but decreased thereafter, fitting with increased release of the CTSS endogenous inhibitor, cystatin C, during differentiation. Inhibition of CTSS activity by an exogenous-specific inhibitor added along the differentiation, resulted in a 2-fold reduction of lipid content and expression of adipocyte markers in differentiated cells. Conversely, the treatment of preadipocytes with human recombinant CTSS increased adipogenesis. Moreover, CTSS supplementation in preadipocyte media markedly reduced the fibronectin network, a key preadipocyte-ECM component, the decrease of which is required for adipogenesis. Using immunohistochemistry on serial sections of adipose tissue of obese subjects, we showed that adipose cells staining positive for CTSS are mainly located in the vicinity of fibrosis regions containing fibronectin. Herein we propose that CTSS may promote human adipogenesis, at least in part, by degrading fibronectin in the early steps of differentiation. Taken together, these results indicate that CTSS released locally by preadipocytes promotes adipogenesis, suggesting a possible contribution of this protease to fat mass expansion in obesity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16825321     DOI: 10.1210/en.2006-0386

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  41 in total

1.  Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study.

Authors:  Meredith C Foster; Shih-Jen Hwang; Stacy A Porter; Joseph M Massaro; Udo Hoffmann; Caroline S Fox
Journal:  Hypertension       Date:  2011-09-19       Impact factor: 10.190

Review 2.  Association of cystatin C with adverse outcomes.

Authors:  Magdalena Madero; Mark J Sarnak
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-05       Impact factor: 2.894

3.  Concurrent quantification of proteome and phosphoproteome to reveal system-wide association of protein phosphorylation and gene expression.

Authors:  Yi-Bo Wu; Jie Dai; Xing-Lin Yang; Su-Jun Li; Shi-Lin Zhao; Quan-Hu Sheng; Jia-Shu Tang; Guang-Yong Zheng; Yi-Xue Li; Jia-Rui Wu; Rong Zeng
Journal:  Mol Cell Proteomics       Date:  2009-08-12       Impact factor: 5.911

4.  Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.

Authors:  Chris T Longenecker; Douglas Kitch; Paul E Sax; Eric S Daar; Camlin Tierney; Samir K Gupta; Grace A McComsey
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

5.  Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test.

Authors:  Li Fan; Lesley A Inker; Jerome Rossert; Marc Froissart; Peter Rossing; Michael Mauer; Andrew S Levey
Journal:  Nephrol Dial Transplant       Date:  2014-01-20       Impact factor: 5.992

6.  Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI.

Authors:  Aylin Hatice Yamac; Emrah Sevgili; Sitki Kucukbuzcu; Muharrem Nasifov; Ziya Ismailoglu; Elif Kilic; Cilem Ercan; Parviz Jafarov; Hüseyin Uyarel; Ahmet Bacaksiz
Journal:  Herz       Date:  2015-04-25       Impact factor: 1.443

7.  Association of visceral and subcutaneous adiposity with kidney function.

Authors:  Jill A Young; Shih-Jen Hwang; Mark J Sarnak; Udo Hoffmann; Joseph M Massaro; Daniel Levy; Emelia J Benjamin; Martin G Larson; Ramachandran S Vasan; Christopher J O'Donnell; Caroline S Fox
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 8.237

8.  Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice.

Authors:  Min Yang; Jiusong Sun; Tinghu Zhang; Jian Liu; Jie Zhang; Michael A Shi; Froogh Darakhshan; Michèle Guerre-Millo; Karine Clement; Bruce D Gelb; Gregory Dolgnov; Guo-Ping Shi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-25       Impact factor: 8.311

9.  Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.

Authors:  Lesley A Inker; Christina Wyatt; Rebecca Creamer; James Hellinger; Matthew Hotta; Maia Leppo; Andrew S Levey; Aghogho Okparavero; Hiba Graham; Karen Savage; Christopher H Schmid; Hocine Tighiouart; Fran Wallach; Zipporah Krishnasami
Journal:  J Acquir Immune Defic Syndr       Date:  2012-11-01       Impact factor: 3.731

10.  The impact of demographic characteristics and lifestyle in the distribution of cystatin C values in a healthy greek adult population.

Authors:  Angelos A Evangelopoulos; Natalia G Vallianou; Vassiliki P Bountziouka; Amalia N Giotopoulou; Maria S Bonou; John Barbetseas; Peter C Avgerinos; Demosthenes B Panagiotakos
Journal:  Cardiol Res Pract       Date:  2010-10-14       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.